Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +34.35%
#2 Siren Siren +31.73%
#3 OriginTrail OriginTrail +18.20%
#4 Purr Purr +17.28%
#5 龙虾 (Lobster) 龙虾 (Lobster) +12.28%
#6 Ethena Staked ENA Ethena Staked ENA +11.62%
#7 Wrapped XPL Wrapped XPL +11.23%
#8 DigiByte DigiByte +11.00%
#9 Collect on Fanable Collect on Fanable +10.98%
#10 Plasma Plasma +10.85%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Hemab Therapeutics Holdings, Inc. Common Stock Hemab Therapeutics Holdings, Inc. Common Stock

Hemab Therapeutics Holdings, Inc. Common Stock

COAG
Classificação em ações #21709
Hemab Therapeutics Holdings, Inc. is a clinical-stage biotechnology firm... Hemab Therapeutics Holdings, Inc. is a clinical-stage biotechnology firm dedicated to transforming the treatment of blood coagulation disorders. Operating in the United States and Denmark, its mission is to enhance life and resilience for patients through innovative therapies. The company's leading pipeline candidate is HMB-001, a bispecific antibody. This asset is currently undergoing Phase 1/2 clinical trials for the preventive management of Glanzmann thrombasthenia and has progressed to Phase 2 for the prophylactic treatment of Factor VII deficiency. Additionally, Hemab is advancing HMB-002, a monovalent antibody, through Phase 1/2 clinical development. This drug is designed for the subcutaneous prophylactic treatment of Von Willebrand disease. Beyond these clinical assets, the company actively pursues numerous preclinical and discovery-stage programs. Established in 2020, Hemab Therapeutics Holdings, Inc. maintains its headquarters in Cambridge, Massachusetts.
Preço da ação
$50.82
Última sincronização: 2026-08-11
Valor de mercado
$102.09M
Variação (1 dia)
1.90%
Variação (1 ano)
-
País
US
Negociar Hemab Therapeutics Holdings, Inc. Common Stock (COAG)

Categoria

Healthcare
Preço COAG com a capitalização de mercado de B
Hemab Therapeutics Holdings, Inc. Common Stock Hemab Therapeutics Holdings, Inc. Common Stock
COAG
$50.82
Capitalização de mercado de Hemab Therapeutics Holdings, Inc. Common Stock(COAG)
Valor de mercado: $102.09M
Em August 2026, Hemab Therapeutics Holdings, Inc. Common Stock tem uma capitalização de mercado de $102.09M. Isso faz com que Hemab Therapeutics Holdings, Inc. Common Stock seja a 21709th empresa mais valiosa do mundo em termos de capitalização de mercado, de acordo com os nossos dados. A capitalização de mercado, também chamada de market cap, é o valor total de mercado das ações em circulação de uma empresa de capital aberto e é amplamente utilizada para medir o valor de uma empresa.
Histórico de capitalização de mercado de Hemab Therapeutics Holdings, Inc. Common Stock de 2026 a 2026
COAG comparado com o topo de 5 mais populares stocks
Preço para COAG Ativo B Capitalização de mercado de B Resultados
Hemab Therapeutics Holdings, Inc. Common Stock Hemab Therapeutics Holdings, Inc. Common Stock
$2,594,322 $102.09M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.211T +5,104,822.70%
Hemab Therapeutics Holdings, Inc. Common Stock Hemab Therapeutics Holdings, Inc. Common Stock
$2,263,459 $102.09M
Apple Inc. Apple Inc.
AAPL
$4.547T +4,453,775.23%
Hemab Therapeutics Holdings, Inc. Common Stock Hemab Therapeutics Holdings, Inc. Common Stock
$2,072,162 $102.09M
Alphabet Inc. Alphabet Inc.
GOOG
$4.162T +4,077,354.21%
Hemab Therapeutics Holdings, Inc. Common Stock Hemab Therapeutics Holdings, Inc. Common Stock
$1,788,562 $102.09M
Microsoft Corporation Microsoft Corporation
MSFT
$3.593T +3,519,305.23%
Hemab Therapeutics Holdings, Inc. Common Stock Hemab Therapeutics Holdings, Inc. Common Stock
$1,390,338 $102.09M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.793T +2,735,708.14%